The literature article entitled, ""cementless total hip arthroplasty in young chinese patients" written by k.Y.Chiu, fhkam (ortho surg), w.M.Tang, fhkam (ortho surg), t.P.Ng, fhkam (ortho surg), k.C.Poon, frcs (ed), w.Y.Ho, frcs (ed), and k.M.Lee, afrcse (ed) published by the journal of arthroplasty vol.16 no.7 2001 doi: 10.1054/arth.2001.25505 on 18 april 2001 was reviewed for mdr reportability.The article reports that 27 patients out of 51 received depuy aml implants with the remainder being non depuy.The 27 patients with aml implants had 9 aml acetabular components implanted before 1991 and the remainder 18 had duraloc acetabular components thereafter.The femoral heads were 28 mm in diameter for the aml hips.No further information given regarding materials.Clinical outcomes for the 51 patients include mild pain that did not limit activities (4); revisions (10) for the following reasons: aseptic loosening unspecified anatomical location (1), poly wear with osteolysis (7), late sepsis (2).The article further states: "the acetabular component alone was revised in 2 hips; the acetabular component and the femoral component were revised in 3 hips; the polyethylene liner and the hip ball were exchanged without changing the metal acetabular component or the femoral component in 5 hips.The reoperation rate did not differ significantly between (non depuy product) and aml hips (p 5.53)" the article does not specify which products are related to the clinical outcomes or adverse events.The article notes on radiographic findings: heterotopic ossification was noted in a total of 25 hips out of 51 hips total, 43 hips demonstrated some degree of stress shielding, osteolytic lesions were found around 4 aml acetabular components and 8 femoral components.The article consistently reports no differences of rates or percentages for adverse events between aml and the non-depuy counterpart which indicates that at least one or more of the aforementioned adverse events can be associated with at least one or more depuy aml or duraloc products but exact quantities are unknown.
|
Product complaint # (b)(4).Investigation summary = > no device was received.Root cause undetermined.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|